CD4+ TEG011_CD8α cells produced a significantly higher IFNγ level compared to CD4+ TEG011, which was equivalent to those of TEG011 bulk cells against all tumor targets, without affecting healthy cells. The gene discussed is IFNG; the disease is neoplasm.